SCHEMBL5366292

SCHEMBL5366292

COC(=O)c1cc(N)ccc1Oc1c(F)cccc1F

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 5/20 0.48
ALDH1A1 P00352 4/20 0.41
HSD17B10 Q99714 2/20 0.41
CFTR P13569 1/20 0.41
KDM4E B2RXH2 4/20 0.40
SCN8A Q9UQD0 4/20 0.40
SCN10A Q9Y5Y9 4/20 0.40
GCK P35557 3/20 0.40
KMT2A Q03164 3/20 0.40
POLB P06746 1/20 0.39
MAPT P10636 3/20 0.39
HPGD P15428 2/20 0.39
MEN1 O00255 1/20 0.39
MAPK1 P28482 1/20 0.38
GLA P06280 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
ATM Q13315 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5364608 0.84 ALDH1A1 (0.45) GAAALDH1A1HSD17B10KDM4ESCN8A
SCHEMBL5364354 0.79 MAPT (0.47) GAAALDH1A1KDM4EKMT2AMAPT
SCHEMBL3223768 0.78 HSD17B10 (0.52) GAAALDH1A1HSD17B10CFTRKDM4E
SCHEMBL193418 0.77 GAA (0.61) GAAALDH1A1HSD17B10CFTRKDM4E
SCHEMBL570110 0.77 GAA (0.61) GAAALDH1A1HSD17B10CFTRKDM4E
SCHEMBL31633499 0.77 GAA (0.61) GAAALDH1A1HSD17B10CFTRKDM4E
SCHEMBL6760192 0.77 USP2 (0.53) GAAALDH1A1HSD17B10KDM4EKMT2A
SCHEMBL6566534 0.76 GAA (0.43) GAAALDH1A1HSD17B10CFTRKDM4E
Hydrochloric Acid SCHEMBL6162273 0.76 GAA (0.59) GAAALDH1A1HSD17B10CFTRKDM4E
Hydrochloric Acid SCHEMBL15488205 0.76 GAA (0.59) GAAALDH1A1HSD17B10CFTRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663979-B1 PHENYL OR PYRIDYL AMIDE COMPOUNDS AS PROSTAGLANDIN E2 ANTAGONISTS RAQUALIA PHARMA INC (JP) 2013-10-09 EP disclosed
US-7238714-B2 Aryl or heteroaryl amide compounds PFIZER JAPAN, INC. (JP) 2007-07-03 US disclosed
EP-1663979-A1 PHENYL OR PYRIDYL AMIDE COMPOUNDS AS PROSTAGLANDIN E2 ANTAGONISTS PFIZER INC. (US) 2006-06-07 EP disclosed
US-20050065188-A1 Aryl or heteroaryl amide compounds ASKAT INC. (JP) 2005-03-24 US disclosed
WO-2005021508-A1 PHENYL OR PYRIDYL AMIDE COMPOUNDS AS PROSTAGLANDIN E2 ANTAGONISTS PFIZER INC. (US) 2005-03-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065188-A1 Aryl or heteroaryl amide compounds HRH2, PTGER1, LTB4R2 GAA 2698/4885ALDH1A1 860/4885HSD17B10 618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.